74 MMP | The FDA Is Giving Low-Dose Atropine a Second Chance

Written by Matthew Herzberg

The FDA Is Giving Low-Dose Atropine a Second Chance by The Myopia Mindset

Dr. Cary Herzberg on why the surprise rejection stung, what the advisory committee will weigh, and why an approved drop changes everything for preventive eye care.

Read on Substack
74 MMP | The FDA Is Giving Low-Dose Atropine a Second Chance
The Myopia Mindset
Matthew Herzberg
Previous

75 MMP | Myopia News Monthly — Insurance, Optic Zones, and a Second FDA Swing
Next

73 MMP | The Doctor Who Taught Himself Ortho-K — Dr. Gill on Failure, Math, and Building Doctors Own Design